Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asia Partnerships Critical To Big Pharma’s Drying Pipelines, Merck Exec Tells Bio Korea (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

OSONG, Korea - As big pharma continues snatching up biotechs in its quest to fill drying pipelines, very few biotechs will be left standing in 2013, Merck exec Greg Wiederrecht told Bio Korea attendees Oct. 8.
Advertisement

Related Content

Green Cross To Focus On Biobetters As Korean Biosimilar Space Gets Crowded: Bio Korea Conference
Green Cross To Focus On Biobetters As Korean Biosimilar Space Gets Crowded: Bio Korea Conference
Roche Sets Groundwork For Rapid Expansion In China Through R&D Partnerships
Roche Sets Groundwork For Rapid Expansion In China Through R&D Partnerships
Eli Lilly Global External R&D Director Yetunde Taiwo On Partnering Plans For Discovery Research: An Interview With PharmAsia News
Eli Lilly Global External R&D Director Yetunde Taiwo On Partnering Plans For Discovery Research: An Interview With PharmAsia News
Asia Partnerships Critical To Big Pharma’s Drying Pipelines, Merck Exec Tells Bio Korea (Part 2 of 2)
Alnylam Makes Entry Into Chinese RNAi Market
Alnylam Makes Entry Into Chinese RNAi Market
Alnylam Expands Asian Presence With RNAi License To Japan's GeneDesign

Topics

Advertisement
UsernamePublicRestriction

Register

SC066838

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel